Study guide
Excimer ablation, PRK and LASIK
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Excimer ablation, PRK and LASIK
Key Takeaways Explain This Topic AI
Excimer photoablation changes corneal curvature, with depth depending strongly on optical-zone size.
PRK and LASIK differ in surface healing, flap effects and complication profiles.
Ablation planning requires refractive stability, surface assessment and screening for ectatic disease.
Last updated: October 2026
Keratorefractive surgery encompasses surgical techniques that alter the anterior corneal curvature to modify the total refractive power of the human eye ( + 43.00 D +43.00\text{ D} + 43.00 D out of the total + 60.00 D +60.00\text{ D} + 60.00 D ocular refractive power). By precisely reshaping the stroma, surgeons correct myopia, hyperopia, and astigmatism. A comprehensive understanding of laser-tissue interactions, stromal wound healing kinetics, biomechanical stability, and ectasia risk stratification is fundamental for the European Board of Ophthalmology Diploma (EBOD) examination.
1. Optical Physics of Excimer Laser Photoablation
The excimer (excited dimer) laser operates in the far ultraviolet spectrum at 193 nm , generated by an electrical discharge through a gaseous mixture of argon and fluorine ( ArF ). Each 193 nm photon carries an energy of 6.4 electron volts (eV) , which exceeds the intermolecular covalent binding energy of corneal peptide and collagen bonds (typically 3.6 eV 3.6\text{ eV} 3.6 eV for carbon-carbon and carbon-nitrogen bonds).
Photochemical Ablation (Photoablation)
Rather than burning or vaporising tissue through thermal heating, the 193 nm laser induces photodecomposition (photochemical ablation):
High-energy ultraviolet photons are absorbed within a microscopic superficial layer of hydrated stromal tissue ( < 1 μ m < 1\,\mu\text{m} < 1 μ m penetration depth).
Covalent molecular bonds are directly cleaved within picoseconds.
The fragmented molecular products undergo explosive supersonic expansion and ejection away from the stromal surface.
Surrounding adjacent tissue experiences negligible collateral thermal damage ( < 0.3 – 0.5 μ m < 0.3–0.5\,\mu\text{m} < 0.3–0.5 μ m thermal zone of coagulation).
Each standard laser pulse reliably ablates approximately 0.25 μ m 0.25\,\mu\text{m} 0.25 μ m of corneal stroma at a fluence of 160 – 200 mJ/cm 2 160–200\text{ mJ/cm}^2 160–200 mJ/cm 2 .
Munnerlyn's Formula for Ablation Depth
The mathematical foundation of myopic excimer photoablation was established by Charles Munnerlyn. To correct a spherical myopic error by flattening the central corneal curvature, the laser ablates a central lenticule of tissue according to the parabolic equation: t = S 2 × D 3 t = \frac{S^2 \times D}{3} t = 3 S 2 × D
where:
- t t t is the central ablation depth in micrometres ( μ m \mu\text{m} μ m )
- S S S is the diameter of the optical zone in millimetres ( mm \text{mm} mm )
- D D D is the dioptric power of refractive correction in dioptres ( D \text{D} D )
- The Quadratic Impact of the Optical Zone
Because the optical zone diameter ( S S S ) is squared in Munnerlyn's formula, even small increments in optical zone size produce dramatic increases in central tissue ablation. Conversely, ablation depth scales linearly with dioptric correction ( D D D ):
Myopic Correction ( D D D ) Optical Zone ( S = 5.5 mm S = 5.5\text{ mm} S = 5.5 mm ) Optical Zone ( S = 6.0 mm S = 6.0\text{ mm} S = 6.0 mm ) Optical Zone ( S = 6.5 mm S = 6.5\text{ mm} S = 6.5 mm ) Optical Zone ( S = 7.0 mm S = 7.0\text{ mm} S = 7.0 mm )
− 3.00 D -3.00\text{ D} − 3.00 D 30.25 μ m 30.25\,\mu\text{m} 30.25 μ m 36.00 μ m 36.00\,\mu\text{m} 36.00 μ m 42.25 μ m 42.25\,\mu\text{m} 42.25 μ m 49.00 μ m 49.00\,\mu\text{m} 49.00 μ m
− 6.00 D -6.00\text{ D} − 6.00 D 60.50 μ m 60.50\,\mu\text{m} 60.50 μ m 72.00 μ m 72.00\,\mu\text{m} 72.00 μ m 84.50 μ m 84.50\,\mu\text{m} 84.50 μ m 98.00 μ m 98.00\,\mu\text{m} 98.00 μ m
− 9.00 D -9.00\text{ D} − 9.00 D 90.75 μ m 90.75\,\mu\text{m} 90.75 μ m 108.00 μ m 108.00\,\mu\text{m} 108.00 μ m 126.75 μ m 126.75\,\mu\text{m} 126.75 μ m 147.00 μ m 147.00\,\mu\text{m} 147.00 μ m
Important
Expanding the optical zone from 6.0 mm 6.0\text{ mm} 6.0 mm to 7.0 mm 7.0\text{ mm} 7.0 mm for a − 6.00 D -6.00\text{ D} − 6.00 D myopic treatment increases the central stromal tissue depth required from 72 μ m 72\,\mu\text{m} 72 μ m to 98 μ m 98\,\mu\text{m} 98 μ m —an additional 36 % 36\% 36% increase in tissue removal ( 98 / 72 = 1.361 98 / 72 = 1.361 98/72 = 1.361 ). Selecting an optical zone smaller than the patient's mesopic pupil diameter causes severe nocturnal glare, starbursts, and loss of contrast sensitivity due to induced spherical aberrations ( Z 4 0 Z_4^0 Z 4 0 ).
2. Photorefractive Keratectomy (PRK) & Advanced Surface Ablation
Surface ablation eliminates corneal tissue directly from the anterior stromal surface after removing or displacing the corneal epithelium, permanently removing Bowman layer. Variations include Photorefractive Keratectomy ( PRK ), Laser Epithelial Keratomileusis ( LASEK ), Epipolis-LASIK ( epi-LASIK ), and Transepithelial PRK ( transPRK ).
Epithelial Debridement Techniques
Mechanical Debridement : Epithelium is scraped centrally using a blunt hockey-knife blade or an automated rotating brush (Amoils brush).
Chemical Debridement (Alcohol-Assisted / LASEK) : A well containing 20 % 20\% 20% dilute ethanol in balanced salt solution is placed on the central cornea for 20 – 30 seconds 20–30\text{ seconds} 20–30 seconds , loosening hemidesmosomal attachments along the basement membrane zone. In classic PRK, the epithelial sheet is discarded; in LASEK, the sheet is folded back and repositioned over the stromal bed following ablation.
Transepithelial PTK/PRK (transPRK) : A single continuous laser sequence where a preliminary phototherapeutic keratectomy (PTK) profile ablates the epithelial layer (typically calibrated to 50 – 55 μ m 50–55\,\mu\text{m} 50–55 μ m centrally) followed immediately by the refractive excimer ablation without manual manipulation.
Corneal Wound Healing & Postoperative Haze Pathogenesis
Epithelial injury in surface ablation initiates an aggressive wound healing cascade:
Damaged epithelial cells release pro-inflammatory cytokines, predominantly interleukin-1 α \alpha α (IL-1 α \alpha α ) , IL-1 β \beta β , and tumor necrosis factor- α \alpha α (TNF- α \alpha α ) .
These cytokines diffuse into the underlying anterior stroma, triggering immediate keratocyte apoptosis across the anterior 50 – 100 μ m 50–100\,\mu\text{m} 50–100 μ m .
Over the subsequent 2 to 4 weeks, surviving quiescent keratocytes in the posterior stroma and periphery proliferate and migrate into the depleted anterior bed under the influence of transforming growth factor- β \beta β (TGF- β \beta β ) and platelet-derived growth factor (PDGF) derived from the regenerating epithelium and tear film.
Activated keratocytes differentiate into myofibroblasts , which express α \alpha α -smooth muscle actin ( α \alpha α -SMA) and secrete abnormal, unorganised type III collagen, biglycan, and decorin, leading to subepithelial reticular opacity known as corneal haze .
Mitomycin C and Surface Healing
Mitomycin C suppresses proliferating cells through DNA cross-linking and may reduce PRK haze in selected higher-risk treatments. Concentration and exposure are protocol-specific; it is not a guarantee against haze. Avoid uncontrolled exposure and protect the endothelium. Follow epithelial closure, infection and pressure, and distinguish haze from recurrent dystrophy or ectasia.
3. Laser In Situ Keratomileusis (LASIK)
In LASIK, a partial-thickness lamellar corneal flap is created and reflected, the exposed intrastromal bed is reshaped with the excimer laser, and the flap is repositioned without sutures. Sparing Bowman layer and the central epithelium provides rapid visual recovery (within 24 hours) and minimal postoperative pain compared to PRK.
Microkeratome vs. Femtosecond Laser Flap Creation
Parameter Mechanical Microkeratome (Blade) Femtosecond Laser (1053 nm Nd:glass)
Mechanism Oscillating motorized stainless steel blade advancing across vacuum suction ring Infrared laser-induced optical breakdown (LIOB); micro-cavitation plasma bubbles of CO 2 \text{CO}_2 CO 2 and H 2 O \text{H}_2\text{O} H 2 O
Flap Morphology Meniscus shape : thinner centrally, thicker in the periphery Planar shape : uniform thickness across entire diameter
Flap Thickness Precision High variability (target 130 – 160 μ m ± 25 – 30 μ m 130–160\,\mu\text{m} \pm 25–30\,\mu\text{m} 130–160 μ m ± 25–30 μ m ) Exceptional reproducibility (target 90 – 110 μ m ± 5 – 10 μ m 90–110\,\mu\text{m} \pm 5–10\,\mu\text{m} 90–110 μ m ± 5–10 μ m )
Side-Cut Architecture Shallow bevelled angle ( 30 ∘ – 45 ∘ 30^\circ–45^\circ 3 0 ∘ –4 5 ∘ ) Customisable vertical or inverted bevelled angle ( 70 ∘ – 110 ∘ 70^\circ–110^\circ 7 0 ∘ –11 0 ∘ )
Biomechanical Stability Lower wound re-apposition strength; higher risk of displacement Superior interlocking flap-bed adhesion; higher tensile resistance
Epithelial Ingrowth Risk Higher ( 1 – 2 % 1–2\% 1–2% ) due to shallow side cuts Significantly lower ( < 0.2 % < 0.2\% < 0.2% ) due to tight vertical/undercut edges
Intraoperative Complications Free caps, buttonholes, incomplete passes Suction loss, Opaque Bubble Layer (OBL), transient light sensitivity
Tip
Inverted bevelled side cuts ( 90 ∘ – 110 ∘ 90^\circ–110^\circ 9 0 ∘ –11 0 ∘ ) created by femtosecond lasers act as a mechanical "manhole cover", preventing sliding displacement and providing superior tectonic resistance against late traumatic dislocation compared to microkeratome flaps.